Certara stock.

Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55.

Certara stock. Things To Know About Certara stock.

Q3 2023 Certara Inc Earnings Call. Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing.View Certara, Inc CERT investment & stock information. Get the latest Certara, Inc CERT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.110 Salaries (for 72 job titles) • Updated Nov 20, 2023. How much do Certara employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Our model gets smarter over time as more people share …In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ...Latest Software and Certara Inc, Blackbaud Inc Stock News. As of November 22, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $426.2 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price ...

Which Certara insiders have been buying company stock? The following insiders have purchased CERT shares in the last 24 months: Eran Broshy ($3,107.30), Michael Andrew Schemick ($416,000.00), and Stephen M Mclean ($326,400.00).Certara has launched a series of interactive educational webinars to teach users how to build PK and PK/PD models in Phoenix. This series is called the Phoenix Modeling Language School or PML School. The series will cover scenarios such as simultaneous fitting of IV and PO data, target-mediated drug disposition, enterohepatic recirculation ...

Feb 2, 2022 · Certara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ... A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a price target for 20.00 expecting CERT to rise to within ...

Nov 30, 2023 · Stock analysis for Certara Inc (CERT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Legal Name Certara, Inc. Stock Symbol NASDAQ:CERT. Company Type For Profit. Contact Email [email protected]. Phone Number 415-237-8272. Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include …Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ... William Blair Investment Management LLC grew its position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) by 4.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,026,786 shares of the company's s

Mar 29, 2021 · PRINCETON, N.J.– March 29, 2021 –Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 11,500,000 shares of its common stock by certain existing stockholders at a public offering price of $25.00 per share. The closing includes 1,500,000 shares sold upon full ...

Certara Inc Registered Shs Aktie Profil Die Certara Inc Registered Shs Aktie wird unter der ISIN US15687V1098 an den Börsen Hamburg, Berlin, NASDAQ, Bats, NASDAQ Bsc, Tradegate und Lang & Schwarz ...

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ...Nov 14, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 14, 2023, 4:00 PM, CST, Certara Inc’s stock price was $14.49. Certara Inc is up 11.29% from its previous closing price of $13.02. During the last market session, Certara Inc’s stock traded between $12.99 and $13.66. Currently, there are 159.17 million shares of Certara Inc stock ... Mason Slaine CERT stock SEC Form 4 insiders trading. Mason has made over 9 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Mason sold 250,000 units of CERT stock worth $3,890,000 on 14 November 2022.. The largest trade Mason's ever made was selling 620,668 units of Certara stock …Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ...Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio.GOEV | Complete Canoo Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Certara Inc’s Stock Price as of Market Close. As of November 10, 2023, 4:00 PM, CST, Certara Inc’s stock price was $13.50. Certara Inc is up 6.72% from its previous closing price of $12.65. During the last market session, Certara Inc’s stock traded between $12.61 and $13.36. Currently, there are 159.17 million shares of Certara Inc stock ...Mar 14, 2023 · Certara, Inc. (CERT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year ... May 8, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? 7 Nov 2022 ... png. Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase. Arsenal will acquire ...Stock Price Statistics The stock price has decreased by -5.73% in the last 52 weeks. The beta is 1.51, so Certara's price volatility has been higher than the market average.

While strong estimate revisions for Certara, Inc. have attracted decent investments and pushed the stock 13.2% higher over the past four weeks, further upside may still be left in the stock.The estimated Net Worth of Leif E Pedersen is at least $6.02 Million dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $3,161,396 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.

May 8, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? Certara is listed on the Nasdaq stock exchange under the ticker symbol “CERT.” When did Certara go public, and what was the offering price? Certara’s initial public offering was on December 11, 2020 at $23 per share.Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $54,863 on 31 March 2023.3,990 units of CERT stock worth $54,863 on 31 March 2023.PRINCETON, NJ.—. December 3, 2020 – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling ...Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...CHPT | Complete ChargePoint Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.11 Okt 2023 ... 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial ...According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...

Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.. The largest trade Patrick's ever made was selling 19,104 units of Certara stock on 5 June …

According to the issued ratings of 15 analysts in the last year, the consensus rating for Devon Energy stock is Moderate Buy based on the current 6 hold ratings, 8 buy ratings and 1 strong buy rating for DVN. The average twelve-month price prediction for Devon Energy is $57.82 with a high price target of $77.00 and a low price target of $48.00.

Matthew Walsh CERT stock SEC Form 4 insiders trading. Matthew has made over 12 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently Matthew exercised 9,067 units of CERT stock worth $135,642 on 17 May 2023.. The largest trade Matthew's ever made was exercising 102,043 units of …Robert Aspbury CERT stock SEC Form 4 insiders trading. Robert has made over 7 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Robert exercised 8,646 units of CERT stock worth $211,049 on 31 March 2023.8,646 units of CERT stock worth $211,049 on 31 March 2023.Michael Schemick CERT stock SEC Form 4 insiders trading. Michael has made over 8 trades of the Certara stock since 2019, according to the Form 4 filled with the SEC. Most recently Michael exercised 13,302 units of CERT stock worth $199,131 on 31 March 2023.. The largest trade Michael's ever made was selling 66,667 units of Certara …The high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …Find the latest Oshkosh Corporation (OSK) stock quote, history, news and other vital information to help you with your stock trading and investing.11 Jan 2022 ... Get Certara Inc (CERT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.5 brokerages have issued 1-year price objectives for Elanco Animal Health's stock. Their ELAN share price targets range from $9.50 to $16.00. On average, they anticipate the company's share price to reach …A Barchart Premier membership lets you screen on these options using advanced filters, including strategies for Covered Calls, Naked Puts and Option Spreads ...Nov 23, 2023 · Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%. Mar 17, 2023 · In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ... Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis.

If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Follow. PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in ...Presentation Operator MessageOperator Good day, and thank you for standing by. Welcome to the Certara Third Quarter 2023 Earnings Conference Call. [Operator Instructions] ... Stock Certara, Inc. - Nasdaq . News Certara, Inc. Transcript : Certara, Inc., Q3 2023 Earnings Call, Nov 08, 2023. CATEGORIES. Indexes; Equities ...Instagram:https://instagram. fha loans michiganfinancial advisors wichita kshcm software markettesla stock future Certara, Inc. (NASDAQ: CERT) stock sentiment score is-15 as of the last check on Friday, November 03.That’s a change of -50.00 points from its previous day’s sentiment score of 35.00.-50.00 points from its previous day’s sentiment score of 35.00.Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT. atandt dividends historycan i trade forex on td ameritrade Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its … financial planner nashville Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Success is Achieved Together. Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.